View in EDS

Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.
Authors: Touzeau C; Service d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes Université, 5 All. de l'Île Gloriette, 44000, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr.; Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, INSERM, Centre National de la Recherche Scientifique, Université d'Angers, Université de Nantes, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr.; Site de Recherche Intégrée sur le Cancer, Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), French National Cancer Institute-French Ministry of Health-INSERM, 12558, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr., Lipe B; University of Rochester Medical Center, Rochester, NY, USA., Khan AM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Dhakal B; Medical College of Wisconsin, Milwaukee, WI, USA., Nair S; Johnson & Johnson, Beerse, Belgium., He J; Johnson & Johnson, Raritan, NJ, USA., Mendes J; Johnson & Johnson, Raritan, NJ, USA., Lee S; Johnson & Johnson, Raritan, NJ, USA., Lonardi C; Johnson & Johnson, Buenos Aires, Argentina., Slaughter A; Johnson & Johnson, Zug, Switzerland., Lendvai N; Johnson & Johnson, Raritan, NJ, USA., Schecter JM; Johnson & Johnson, Raritan, NJ, USA., Chen D; Johnson & Johnson, Shanghai, China., Zhao M; IQVIA, Shanghai, China., Yeh TM; Johnson & Johnson, Raritan, NJ, USA., Leleu X; CHU Poitiers, Poitiers, France., Puig N; Centro de Investigación del Cancer, Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Dytfeld D; Poznan University of Medical Sciences, Poznań, Poland., Zamagni E; University of Bologna, Bologna, Italy., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Karlin L; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Delforge M; University of Leuven, Leuven, Belgium., Corradini P; Divisione di Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori, Università di Milano, Milan, Italy., Mina R; The Division of Hematology, AOU Citt. della Salute e della Scienza di Torino, and the Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy., Roeloffzen W; University Medical Center Groningen, Groningen, Netherlands., Sidana S; Stanford University School of Medicine, Stanford, CA, USA.
Source: Advances in therapy [Adv Ther] 2025 Oct; Vol. 42 (10), pp. 5023-5041. Date of Electronic Publication: 2025 Aug 06.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40768190
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Touzeau+C%22">Touzeau C</searchLink>; Service d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes Université, 5 All. de l'Île Gloriette, 44000, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr.; Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, INSERM, Centre National de la Recherche Scientifique, Université d'Angers, Université de Nantes, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr.; Site de Recherche Intégrée sur le Cancer, Imaging and Longitudinal Investigations to Ameliorate Decision-Making (ILIAD), French National Cancer Institute-French Ministry of Health-INSERM, 12558, Nantes, France. Cyrille.TOUZEAU@chu-nantes.fr.<br /><searchLink fieldCode="AU" term="%22Lipe+B%22">Lipe B</searchLink>; University of Rochester Medical Center, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Khan+AM%22">Khan AM</searchLink>; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Dhakal+B%22">Dhakal B</searchLink>; Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Nair+S%22">Nair S</searchLink>; Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22He+J%22">He J</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Mendes+J%22">Mendes J</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lonardi+C%22">Lonardi C</searchLink>; Johnson & Johnson, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Slaughter+A%22">Slaughter A</searchLink>; Johnson & Johnson, Zug, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lendvai+N%22">Lendvai N</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Schecter+JM%22">Schecter JM</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chen+D%22">Chen D</searchLink>; Johnson & Johnson, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhao+M%22">Zhao M</searchLink>; IQVIA, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yeh+TM%22">Yeh TM</searchLink>; Johnson & Johnson, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; CHU Poitiers, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Puig+N%22">Puig N</searchLink>; Centro de Investigación del Cancer, Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Dytfeld+D%22">Dytfeld D</searchLink>; Poznan University of Medical Sciences, Poznań, Poland.<br /><searchLink fieldCode="AU" term="%22Zamagni+E%22">Zamagni E</searchLink>; University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Karlin+L%22">Karlin L</searchLink>; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Delforge+M%22">Delforge M</searchLink>; University of Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Corradini+P%22">Corradini P</searchLink>; Divisione di Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori, Università di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Mina+R%22">Mina R</searchLink>; The Division of Hematology, AOU Citt. della Salute e della Scienza di Torino, and the Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Roeloffzen+W%22">Roeloffzen W</searchLink>; University Medical Center Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Sidana+S%22">Sidana S</searchLink>; Stanford University School of Medicine, Stanford, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Oct; Vol. 42 (10), pp. 5023-5041. <i>Date of Electronic Publication: </i>2025 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40768190
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-025-03308-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5023
    Titles:
      – TitleFull: Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Touzeau C
      – PersonEntity:
          Name:
            NameFull: Lipe B
      – PersonEntity:
          Name:
            NameFull: Khan AM
      – PersonEntity:
          Name:
            NameFull: Dhakal B
      – PersonEntity:
          Name:
            NameFull: Nair S
      – PersonEntity:
          Name:
            NameFull: He J
      – PersonEntity:
          Name:
            NameFull: Mendes J
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Lonardi C
      – PersonEntity:
          Name:
            NameFull: Slaughter A
      – PersonEntity:
          Name:
            NameFull: Lendvai N
      – PersonEntity:
          Name:
            NameFull: Schecter JM
      – PersonEntity:
          Name:
            NameFull: Chen D
      – PersonEntity:
          Name:
            NameFull: Zhao M
      – PersonEntity:
          Name:
            NameFull: Yeh TM
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Puig N
      – PersonEntity:
          Name:
            NameFull: Dytfeld D
      – PersonEntity:
          Name:
            NameFull: Zamagni E
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Karlin L
      – PersonEntity:
          Name:
            NameFull: Delforge M
      – PersonEntity:
          Name:
            NameFull: Corradini P
      – PersonEntity:
          Name:
            NameFull: Mina R
      – PersonEntity:
          Name:
            NameFull: Roeloffzen W
      – PersonEntity:
          Name:
            NameFull: Sidana S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1